2022
DOI: 10.3390/cells11182832
|View full text |Cite
|
Sign up to set email alerts
|

Depletion of VGLL4 Causes Perinatal Lethality without Affecting Myocardial Development

Abstract: Congenital heart disease is one of the leading causes of pediatric morbidity and mortality, thus highlighting the importance of deciphering the molecular mechanisms that control heart development. As the terminal transcriptional effectors of the Hippo–YAP pathway, YAP and TEAD1 form a transcriptional complex that regulates the target gene expression and depletes either of these two genes in cardiomyocytes, thus resulting in cardiac hypoplasia. Vestigial-like 4 (VGLL4) is a transcriptional co-factor that intera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 39 publications
0
6
0
Order By: Relevance
“…Few functional validation studies with genetically engineered mouse models (GEMM) for homozygous deletion of VGLL4 as a driver have been conducted (Cai et al, 2022). Indeed GEMM studies have mostly focused on the role of VGLL4 in development (Sheldon et al, 2022) rather than cancer. It is only very recently because of the recognition of VGLL4’s importance as a negative regulator of the YAP/TEAD oncogenic transcriptional complex ( Figure 12 ) that dedicated GEMM studies with cancer have been undertaken.…”
Section: Resultsmentioning
confidence: 99%
“…Few functional validation studies with genetically engineered mouse models (GEMM) for homozygous deletion of VGLL4 as a driver have been conducted (Cai et al, 2022). Indeed GEMM studies have mostly focused on the role of VGLL4 in development (Sheldon et al, 2022) rather than cancer. It is only very recently because of the recognition of VGLL4’s importance as a negative regulator of the YAP/TEAD oncogenic transcriptional complex ( Figure 12 ) that dedicated GEMM studies with cancer have been undertaken.…”
Section: Resultsmentioning
confidence: 99%
“…We previously showed that activation of VGLL4 decreased TEAD1 protein level in the heart (Lin et al, 2016) and knocking out VGLL4 increased TEAD1 (Sheldon et al, 2022). We then checked whether inactivation of VGLL4 affected TEAD1 protein expression in BAT.…”
Section: Deletion Of Vgll4 Activates Igf-akt Pathwaymentioning
confidence: 98%
“…We have previously reported that whole-body depletion of VGLL4 led to perinatal death (Sheldon et al, 2022). While characterizing the phenotype of the Vgll4 knockout (Vko) pups, we noticed that the Vko newborn pups had consistent dents in the interscapular regions, which led us to examine the interscapular BAT depot.…”
Section: Mutating Vgll4 Causes Bat Paucitymentioning
confidence: 98%
See 1 more Smart Citation
“…In Xenopus and zebrafish the transcripts of the different vgll4 paralogs show a dynamic developmental expression pattern in different tissues ( Faucheux et al, 2010 ; Barrionuevo et al, 2014 ; Xue et al, 2018 ) and in zebrafish the mRNA of two ( Xue et al, 2018 ) ( vgll4a ; vgll4b ) of the three paralogs ( vgll4a , vgll4b and vgll4l ) have been detected at the 1 cell stage ( Xue et al, 2018 ), suggesting a possible early function. Although there are additional and species-specific phenotypes that involve later developing organs ( Fillatre et al, 2019 ; Xue et al, 2019 ; Wang et al, 2020 ), loss of function studies in mice and analysis of genetic variants in the teleost Scatophagus argus suggest that Vgll4 participates in the regulation of body size ( Feng et al, 2019 ; Suo et al, 2020 ; Yang et al, 2020 ; Sheldon et al, 2022 ), a trait that is often altered as the consequence of an abnormal gastrulation.…”
Section: Introductionmentioning
confidence: 99%